The DOI matches its Crossref record.
Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats.
Open accessAbstract
This experiment was designed to investigate the effect of converting enzyme inhibition on functional and structural vascular alterations in one-kidney, one clip hypertensive rats and in normotensive rats. Starting 1 day before surgery, 100 mg/kg/day captopril was given chronically to half of the hypertensive and normotensive groups in their drinking water. With use of intravital microscopy in the cremaster muscle, arteriolar dimensions were measured 4 weeks later, both before and after topical application of 10(-3) M adenosine. Mean blood pressure was 124 +/- 4 mm Hg in control rats and 103 +/- 5 mm Hg in captopril-treated control rats (p less than 0.05). Mean blood pressure was significantly elevated to 183 +/- 5 mm Hg in captopril-treated one-kidney, one clip hypertensive rats and 193 +/- 5 mm Hg in one-kidney, one clip hypertensive rats. With use of histological techniques, a marked reduction of medial-intimal area of the abdominal aorta was found in captopril-treated control rats (24%), and hypertrophy of the aortic wall in one-kidney, one clip hypertensive rats was decreased 26% by captopril. Structural diameter reductions occurred in large arterioles of the captopril-treated control and hypertensive groups and the nontreated hypertensive group. In spite of a significant increase in wall-to-lumen ratio of first-order arterioles in all captopril-treated rats, captopril decreased cross-sectional wall area of these vessels 37% in hypertensive and 20% in control rats, respectively. Measured by stereological techniques, small arteriolar density decreased 30% in captopril-treated hypertensive rats and 17% in captopril-treated control rats. Therefore, smaller arteriolar lumens, decreased aortic and arteriolar cross-sectional wall area, and arteriolar rarefaction after converting enzyme inhibition, in spite of rising or falling blood pressure, are evidence that vascular growth was inhibited in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism.
Griffin, S. A., Brown, W. C., MacPherson, F., McGrath, J. C., Wilson, V. G., Korsgaard, N., Mulvany, M. J., & Lever, A. F. (1991) · Hypertension · doi:10.1161/01.hyp.17.5.626 · Cited by 391
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
Itoh, H., Pratt, R. E., & Dzau, V. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114893 · Cited by 326
Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats.
Volpert, O. V., Ward, W. F., Lingen, M. W., Chesler, L., Solt, D. B., Johnson, M. D., Molteni, A., Polverini, P. J., & Bouck, N. P. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118838 · Cited by 323
Opposing Actions of Angiotensin II on Microvascular Growth and Arterial Blood Pressure
Munzenmaier, D. H., & Greene, A. S. (1996) · Hypertension · doi:10.1161/01.hyp.27.3.760 · Cited by 288
Angiotensin actions in the kidney: Renewed insight into the old hormone
Ichikawa, I., & Harris, R. C. (1991) · Kidney International · doi:10.1038/ki.1991.249 · Cited by 284
Metadata
- Authors
- Wang, D. H., & Prewitt, R. L.
- Venue
- Hypertension
- Published
- 1990-01
- Volume
- 15
- Issue
- 1
- Pages
- 68-77
- ISSN
- 0194-911X (ISSN-L)
- 1524-4563
- OpenAlex
- W2084279444
- Cited by
- 164
- References
- 0
- FWCI
- 9.54
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. https://app.cochat.ai/papers/10.1161/01.hyp.15.1.68
- The paper
- Wang, D. H., & Prewitt, R. L. (1990). Captopril reduces aortic and microvascular growth in hypertensive and normotensive rats. Hypertension. https://doi.org/10.1161/01.hyp.15.1.68
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.